System and apparatus for point-of-care diagnostics
US-2016054316-A1 · Feb 25, 2016 · US
US11061020B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11061020-B2 |
| Application number | US-201313783065-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 1, 2013 |
| Priority date | Mar 1, 2012 |
| Publication date | Jul 13, 2021 |
| Grant date | Jul 13, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A system comprised of an apparatus and a test device is described. The test device and the apparatus are designed to interact to determine the presence or absence of an analyte of interest in a sample placed on the test device. The test device and apparatus interact to provide a timer feature for determining a test device specific adjustable cut-off value that is used to ascertain whether signal from a test line in the device corresponds to a positive or negative results, irrespective of the time elapsed since placement of sample on the test device. The adjustable cut-off value renders the system relatively insensitive to incubation time of the test device, where if the incubation time is shorter or longer than needed for accuracy of a test result, the analyzer will report an invalid result, thus preventing the reporting of an incorrect (false negative or false positive) result.
Opening claim text (preview).
It is claimed: 1. A system, comprising: a test device comprising: (a) a label zone comprising (i) a first population of mobilizable, detectable particles for specific binding to a test analyte in a sample; and (ii) a second population of mobilizable, detectable particles for specific binding to a non-test analyte but not to the test analyte; (b) a first detection site at a first position comprising a first binding member having specific binding affinity for detectable particles in the first population bound to the test analyte; and (c) a second detection site at a second position that is separate from the first position, the second detection site comprising a second binding member having specific binding affinity for detectable particles in the second population bound to the non-test analyte; and an analyzer comprising: (1) a drawer dimensioned to receive the test device, (2) an optical system for detection of a signal generated from the first population of mobilizable, detectable particles at the first position and the second population of mobilizable, detectable particles at the second position when each population reaches a specific and separate position on the test device, (3) a motor to move a detector in the optical system from the first detection site to the second detection site, (4) a processor communicatively coupled with the optical system to receive the signal from the detector and to evaluate a ratio of a signal detected from all or a portion of the first population of mobilizable, detectable particles to a cut-off value to determine a presence or an absence of analyte in the sample based on the ratio, and (5) a memory storing the cut-off value, wherein the cut-off value is an exponentially transformed signal from all or a portion of the second population of mobilizable, detectable particles, adjusted by a constant value empirically determined for a manufacturing lot comprising the test device. 2. The system of claim 1 , wherein the signal from all or a portion of the first population of mobilizable, detectable particles is used by the processor to provide a quantitative or semi-quantitative amount of analyte present in the sample. 3. The system of claim 1 , wherein signal from the second population of mobilizable, detectable particles is mathematically transformed by the processor in the analyzer to provide a transformed signal. 4. The system of claim 3 , wherein the signal from the second population of mobilizable, detectable particles is mathematically transformed by the processor using an exponential transformation. 5. The system of claim 4 , wherein the exponential transformation is selected from an exponential value of between 1.3-1.8. 6. The system of claim 1 , wherein the test device is a lateral flow immunoassay. 7. The system of claim 6 , wherein one or both of the first population of mobilizable, detectable particles and the second population of mobilizable, detectable particles is comprised of particles comprised of a fluorescing lanthanide compound. 8. The system of claim 7 , wherein the fluorescing lanthanide compound is europium.
based on lateral flow · CPC title
Apparatus specially adapted for immunological test procedures · CPC title
with a particulate label, e.g. coloured latex · CPC title
Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation · CPC title
using diffusion or migration of antigen or antibody {(immunochromatographic test strips G01N33/54387)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.